Pfizer Explores Options for Animal Health and Nutrition

Xconomy New York — 

The long-speculated breakup of New York-based pharmaceutical giant Pfizer (NYSE: PFE) seems to be taking a giant step forward today. The company is “exploring strategic alternatives” for its animal health and nutrition units, so it can better focus on its drug-development and consumer-health pursuits, according to a press release. Pfizer Animal Health is one of the world’s largest providers of medicines, tests, and vaccines for livestock and pets, generating $3.6 billion in revenues last year. Pfizer Nutrition makes infant formula and nutritional products that brought in $1.9 billion in sales in 2010. Pfizer says the options for the businesses include a spin-off or sale, and the company might ultimately pursue separate strategies for the two units.

By posting a comment, you agree to our terms and conditions.

2 responses to “Pfizer Explores Options for Animal Health and Nutrition”

  1. Good blog. Keep it the same and always show us new things. Will come back and check this again. Keep sharing.